Glaxosmithkline plc

Major-Pharmaceuticals

GSK


980 Great West Road
Brentford , TW8 9GS

Executive/
Director

Price

  • Last Close
  • $ 33.46
    $ -0.49 -1.44 %
    Jan 3, 2025
  • 52-Week High/Low
  • $44.76 - $34.17
  • YTD
  • -1.1%

  • Trading Volume
  • 72,085
  • Market Cap Full
  • $ 144.3B
  • Shares Outstanding
  • 4311.3M
    Dec 31, 2022
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 3.6% 11% 12.1% 9.4% -5% -2.8% -1% 1.2% 15.7% -1.1%
Q2 8.2% 3.5% 5.1% -4% 4% 11.6% -0.3% 0.2% -8.8% -
Q3 0.6% -4.7% 1.3% 6.7% 8% -3.9% -32.4% 1.7% 12.7% -
Q4 -9.7% -12% -3.5% 9.3% -2.4% 15.2% 19.4% 2.7% -5.9% -
J F M A M J J A S O N D
2025 -1.1% - - - - - - - - - - -
2024 6.4% 6.2% 2.3% -5.3% 10.3% -13.6% 0.4% 12.7% - - - -0.9%
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    -0%2%-3%14%23%-22%20%-20%5%-9%-1%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.57 0.62 0.31 0.44 0.8 0.59 - 0.89
Q2 0.70 0.70 0.24 0.5 1.12 0.78 - 0.99
Q3 0.83 0.85 0.74 0.76 0.64 0.64 - 0.90
Q4 0.65 0.72 0.65 0.67 0.38 3.01 1.50 -
A 2.8 2.9 1.9 2.4 2.9 5 1.5 2.78

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Dividend +

Dividend +

2020 2021 2022 2023 2024 2025
Q1 0.49 0.51 0.51 0.33 0.35 0.38
Q2 0.56 0.63 0.60 0.33 0.40 -
Q3 0.47 0.52 0.42 0.35 0.37 -
Q4 0.49 0.51 0.36 0.34 0.38 -
A 2.01 2.17 1.89 1.35 1.5 0.38
2018 2019 2020 2021 2022
Mar - - - - -
Jun - - - - -
Sep - - - - -
Dec 5379.1 5383.1 5385.2 5387 4311.3

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.9 2 2 2 1.9
Fixed Asset Turnover 2.5 2.5 2.3 2.5 2.2
Total Asset Turnover 0.5 0.4 0.4 0.4 0.5
Leverage
Debt Ratio 0.8 1.1 1.2 1.2 1.2
Debt – Equity Ratio 1.7 1 1.1 1.3 5.5
Interest Coverage -0.8 3.4 3.8 3 3
Equity multiplier 1.2 0.7 0.7 0.7 3.9